BASF increases offer price for acquisition of Pronova BioPharma

14:07 PM | January 15, 2013 | Sotirios Frantzanas

BASF says it has increased its cash-offer price for the proposed acquisition of all of the issued and outstanding shares of Pronova BioPharma (Lysaker, Norway), to 13.50 Norwegian kroner/share ($2.43)...